newsfilter
← Latest News
GlobeNewswire·

Genocea Provides Third Quarter 2020 Corporate Update

Initiated GEN-011 Phase1/2a clinical trial Presented positive follow-up GEN-009 Part B data at ESMO Virtual Congress 2020 demonstrating potential added benefit to PD-1 inhibitor therapy ...